ERLOTINIB DERIVATIVES & USES THEREOF
2012
The present invention relates to compounds useful in the treatment of cancers, in particular cancers overexpressing the epidermal growth factor receptor (EGFR) such as non-small cell lung or breast cancers.
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI